Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma
- PMID: 2834052
Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma
Abstract
Fresh surgical specimens of tumors of 187 patients with previously untreated non-small cell lung carcinomas were investigated by means of flow cytometry. The aim of the study was to look for cellular prognostic indicators for survival times of these patients in addition to the well-known clinical prognostic factors. All patients had a minimum of 5 years follow-up. Patients with aneuploid tumors had significantly shorter survival times than did those with diploid tumors (P less than or equal to 0.001). Identical results are obtained when the analysis is restricted to just those patients with T3 tumors or to patients with metastatic tumors at time of surgery or who were classified as Stage III (P less than or equal to 0.01). These data indicate that DNA ploidy is a strong and independent prognostic factor in patients with non-small cell lung carcinoma. Patients having tumors with a high proliferative activity died significantly (P less than 0.05) earlier than patients having tumors with lower proliferative activity. As with tumor ploidy, survival time in patients with high or low proliferative tumor activities was independent of whether the patients had T3-tumors, metastases, or were in Stage III. Univariate and multivariate analyses of the data in this study demonstrate two groups of independent prognostic factors for the survival of patients with non-small cell lung carcinoma: a group of clinical factors and a group of flow cytometric factors.
Similar articles
-
Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival. A five-year follow up study.Anticancer Res. 1988 Jan-Feb;8(1):105-12. Anticancer Res. 1988. PMID: 3358625
-
[Demonstration of independent cellular prognostic factors in squamous cell carcinoma of the lung].Strahlenther Onkol. 1989 Aug;165(8):587-92. Strahlenther Onkol. 1989. PMID: 2772815 German.
-
[Flow cytometric analysis in non-small-cell bronchial carcinoma and its prognostic significance].Chirurg. 1992 Mar;63(3):205-10. Chirurg. 1992. PMID: 1313755 German.
-
Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.Strahlenther Onkol. 1987 Dec;163(12):791-4. Strahlenther Onkol. 1987. PMID: 2827331
-
Flow cytometry, cellular DNA content, and prognosis in human malignancy.J Clin Oncol. 1987 Oct;5(10):1690-703. doi: 10.1200/JCO.1987.5.10.1690. J Clin Oncol. 1987. PMID: 3309200 Review.
Cited by
-
Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.Am J Pathol. 1992 Dec;141(6):1285-90. Am J Pathol. 1992. PMID: 1361306 Free PMC article.
-
The relevance of flow-cytometric DNA content in the evaluation of lung cancer.J Cancer Res Clin Oncol. 1994;120(4):233-9. doi: 10.1007/BF01372562. J Cancer Res Clin Oncol. 1994. PMID: 8288677 Clinical Trial.
-
Prediction of Cancer Drug Resistance and Implications for Personalized Medicine.Front Oncol. 2015 Dec 17;5:282. doi: 10.3389/fonc.2015.00282. eCollection 2015. Front Oncol. 2015. PMID: 26734568 Free PMC article. Review.
-
DNA-flow cytometry of head and neck carcinoma: the importance of uniform tissue sampling and tumor sites.Eur Arch Otorhinolaryngol. 1992;249(3):140-3. doi: 10.1007/BF00183488. Eur Arch Otorhinolaryngol. 1992. PMID: 1642865
-
Protein expression profiles indicative for drug resistance of non-small cell lung cancer.Br J Cancer. 2002 Jul 29;87(3):251-7. doi: 10.1038/sj.bjc.6600463. Br J Cancer. 2002. PMID: 12177790 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials